TUESDAY, Oct. 14, 2014 (HealthDay News) -- In the future, could people with type 2 diabetes manage their medications with a pulse of light? A preliminary new study suggests it may be possible.
In the study, scientists showed that the prototype drug -- for now just called JB253 -- stimulated insulin release from pancreatic cells in the lab when they were exposed to blue light.
"In principle, this type of
View the Original article
